IMM-27M
- Generic Name
- IMM-27M
A Study of IMM2510 + IMM27M Combination Therapy in Patients With Advanced Solid Tumors
- First Posted Date
- 2025-01-08
- Last Posted Date
- 2025-01-08
- Lead Sponsor
- ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
- Target Recruit Count
- 108
- Registration Number
- NCT06764836
- Locations
- 🇨🇳
ZhongShan Hospital Fudan University, Shanghai, Shanghai, China
Safety and Toxicity Study of IMM27M in Patients With Advanced Solid Tumor
- First Posted Date
- 2022-02-11
- Last Posted Date
- 2023-05-24
- Lead Sponsor
- ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT05235438
- Locations
- 🇨🇳
Henan Cancer Hospital, Henan, China
🇨🇳Sun Yai-Sen Memorial Hospital,Sun Yai-Sen University, Guangzhou, China
🇨🇳Harbin Medical University Cancer Hospital, Harbin, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath